Author

F. Fadilah

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:metabolomics· 1

Frequent Co-Authors

A. Arsianti· 1 shared A. Yanuar· 1 shared L. Erlina· 1 shared R. Andrajati· 1 shared R. I. Paramita· 1 shared U. M. Zuhri· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

6 top collaborators · 10 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiochemistry

A. Arsianti

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Exploration of the main active metabolites from Tinospora crispa (L.) Hook. f. & Thomson stem as insulin sensitizer in L6.C11 skeletal muscle cell by integrating in vitro, metabolomics, and molecular docking

U. M. Zuhri, F. Fadilah

This study identifies active metabolites from Tinospora crispa stem that improve insulin sensitivity in muscle cells through metabolomics and molecular docking.

bioRxiv · Sep 1, 2023 · PreprintPharmacology & Toxicology

Synthesis and in vitro Activity of Eugenyl Benzoate Derivatives as BCL-2 Inhibitor in Colorectal Cancer with QSAR and Molecular Docking Approach

F. Fadilah, R. Andrajati, A. Arsianti, R. I. Paramita, L. Erlina, A. Yanuar

The paper synthesizes eugenyl benzoate derivatives, tests their cytotoxicity against HT29 cells, and uses QSAR analysis to identify structure-activity relationships for BCL-2 inhibition.

bioRxiv · Aug 17, 2020 · PreprintBiochemistry